Hong Sun

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Breast Cancer Cells

Prognostic Factors

Top Venues

Breast cancer (Tokyo, Japan)

Acta diabetologica

This page only lists publications with an associated author ORCID identifier.

Publications

LiRong Zhang, Jiaqin Cai, Huiting Lin, Wenhua Wu, Congting Hu, Xinmiao Lin, Hong Sun, XiaoXia Wei
SGLT-2 inhibitors are beneficial in reducing the risk of thyroid cancer: findings from a Mendelian randomization study. Acta diabetologica (2024)
Yaping Huang, Chengjie Ke, Jiaqin Cai, Xiaoxia Wei, Maohua Chen, Hong Sun
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer. Breast cancer (Tokyo, Japan) (2024)
Yaping Huang, Chengjie Ke, Jiaqin Cai, Xiaoxia Wei, Maohua Chen, Hong Sun
Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer. Breast cancer (Tokyo, Japan) 31 (5) (2024)